ArticlePDF Available

Why do people refuse to take part in biomedical research studies? Evidence from a resource-poor area

Authors:

Abstract and Figures

Participants refusal to take part in research is an unpleasant experience that investigators face. This paper highlights some of the reasons why people from resource-poor settings refuse to take part in health research. This paper also highlights standards which investigators can adopt to avoid unnecessary refusals and at the same time ensure that individuals have the right to participate and freedom to refuse. Our objective was to explore reasons why people refuse to join research studies. We conducted focus group discussions with people who had refused to take part in a number of biomedical research studies but agreed to be interviewed in this study. The study was undertaken in the peri-urban and urban areas of Blantyre district; Bangwe, Mpemba and Madziabango. We found nine key factors that influence people to refuse to participate in biomedical research. The factors are failure to follow traditional customs, lack of study benefits, superstition, poor informed consent procedures, ignorance of health research, fear of strangers, lack of cultural sensitivity, poor timing, and previous bad research experience. People refuse to participate in health research for a number of reasons which can be overcome if researchers embark on community engagement before implementing their studies.
Content may be subject to copyright.
Malawi Medical Journal; 20(2):57 - 63 June 2008
Abstract
Participants’ refusal to take part in research is an unpleasant
experience that investigators face.. This paper highlights
some of the reasons why people from resource-poor
settings refuse to take part in health research. This paper
also highlights standards which investigators can adopt to
avoid unnecessary refusals and at the same time ensure
that individuals have the right to participate and freedom
to refuse. Our objective was to explore reasons why people
refuse to join research studies. We conducted focus group
discussions with people who had refused to take part in a
number of biomedical research studies but agreed to be
interviewed in this study. The study was undertaken in the
peri-urban and urban areas of Blantyre district; Bangwe,
Mpemba and Madziabango. We found nine key factors
that influence people to refuse to participate in biomedical
research. The factors are failure to follow traditional customs
, lack of study benefits, superstition, poor informed consent
procedures, ignorance of health research, fear of strangers,
lack of cultural sensitivity, poor timing, and previous bad
research experience. People refuse to participate in health
research for a number of reasons which can be overcome
if researchers embark on community engagement before
implementing their studies.
Introduction
Ethical conduct in research involving human participants has
become one of the principal challenges faced by researchers.
In recent times, increasing attention has been paid to ethical
implications of carrying out research in settings with low
socio-economic status. This trend has become particularly
central in Africa owing to an increasing number of
multinational research institutions operating in sub-Saharan
African countries.1- 4
The progress of medicine today is a result of biomedical
research which necessarily relies on successful recruitment
of human participants in order to yield meaningful results.
In this sense, human participants are instrumental in
securing data useful to researchers. A participant’s refusal to
participate in research is referred to as a non-response in a
survey.5 For the purpose of this paper, we shall use the term
‘refuser’ to refer to individuals who declined to take part in
research after being approached by research staff.
At the heart of ethical recruitment of participants in a study
is the principle of informed consent. There is a general
consensus amongst researchers, scientists and bioethicists
that acquiring effective informed consent from research
participants is a prerequisite to the conduct of an ethically
sound study6. Among other things, valid informed consent
requires that participation in research should be voluntary
and that individuals should be treated as autonomous agents7.
The requirement for voluntary participation, however, may
result in many people refusing to participate. Refusals are
likely to affect the timeline of research and also compromise
the generalizability of results,8 since it is unclear how people
who refuse differ from those who agree to participate. There
has been limited empirical research aiming to capture the
perspectives of refusers in developing countries.
Many studies have investigated the reasons why people
participate in biomedical research9-12 however, there has
been less research and little attention specifically on reasons
why people refuse to participate in biomedical research.
Most of the data available on refusals are centred on non
response13 to postal questionnaires from different surveys.
In this paper we report findings from an anthropological
and bioethics study of clinical research in Malawi. The study
explored the reasons why people refuse to join biomedical
research and examined possible strategies for minimising
refusals. The participants that were interviewed in this
study had refused to participate in a number of different
biomedical research projects before this study but agreed to
be interviewed in this study. We believe that knowledge of
participants’ perspectives and concerns with their involvement
in research can lead to better recruitment efforts, improve
the informed consent process, and enhance the overall trust
between participants and researchers4.
Many studies have investigated the reasons why people
participate in biomedical research9-12 however, there has
been less research and little attention specifically on reasons
why people refuse to participate in biomedical research. Most
of the data available on refusals is centred on non response13
to postal questionnaires from different surveys.
This paper reports findings from an Anthropological and
Bioethics Study of Clinical Research in Malawi (ABSCRM).
The study explored the reasons why people refuse to join
biomedical research and examined possible strategies for
minimising refusals. The participants that were interviewed in
this study had refused to participate in a number of different
biomedical research projects before this study but agreed
to be interviewed in this study. Knowledge of participants’
perspectives and concerns with their involvement in research
will enhance recruitment efforts, improve the informed
consent process, and enhance the overall trust between
participants and researchers4.
Methods
Design
FFor this study, a qualitative approach was adopted and data
were collected through focus group discussions (FGDs). A
total of 108 refusers were successfully recruited and they
participated in 12 FGDs, each composed of 6-12 people.
The FGD questionnaire guide was translated into the local
Why do people refuse to take part in biomedical
research studies? Evidence from a resource-poor area
Joseph Mfutso-Bengo1, Francis Masiye1, Malcolm Molyneux2, Paul Ndebele1, Abdullah Chilungo1
1. Centre for Bioethics in Eastern and Southern Africa, CEBESA,
College of Medicine, Malawi.
2. The Malawi-Liverpool- Wellcome Trust Research Programme, College
of Medicine, Blantyre, Malawi
Corresponding author: Francis Masiye, Centre for Bioethics in Eastern
and Southern Africa (CEBESA), Department of Community Health,
College of Medicine, Private Bag 360, Chichiri, Blantyre 3, Malawi
Phone: +265 1 871 911, Email: fmasiye@medcol.mw
Why do people refuse to take part in biomedical research studies 58
MMJ 20(2) 2008 www.mmj.medcol.mw
language Chichewa.. All FGDs were recorded on audio tapes
which were then transcribed and translated from Chichewa
into English by members of the research team.
Setting
The study was conducted in Blantyre District, in the
Southern region of Malawi. The specific sites were in the
peri-urban settings of Madziabango and Mpemba health
centre catchment areas, and Bangwe Township which is a
very densely populated urban area. These locations were
selected for this project because several medical research
projects have been conducted there in the past.
Recruitment
Refusers were identified by project staff from the registers
for the various trials which were ongoing at the time. These
registers were maintained at the three sites by the project
staff for the various projects. Each project register had
details of all the participants involved in the study as well
as those who declined to participate after being invited to
enrol. Health Surveillance Assistants (HSAs), who are part
of the community, were then tasked with the responsibility
of following up the refusers in their homes in order to
inform them about the current project and to invite them
to visit the health centres or other specific locations for the
FGDs. Once the individuals had gathered for each FGD our
research team ensured that they all met the eligibility criteria
for refusers... Verbal consent was obtained from those who
agreed to participate in the FGDs. It was difficult to find
sufficient refusers willing to take part in the focus group
discussions. Therefore some FGDs had to be rescheduled.
Data analysis
Analysis of the FGD transcripts was carried out manually
and electronically using computer software N6*. We analysed
the contents of the transcribed texts to identify patterns and
themes that emerged from the data.15 A comparison of major
themes was then made in the final stage of analysis.
Research Ethics Committee Approval
The study was approved by the College of Medicine Research
Ethics Committee (COMREC).
Results
Demographics
Overall, there were more women than men in the refusers’
FGDs. Of the 108 participants, 21% were males and 79%
were females.. There were no significant differences in
average age between the male participants (31 years) and
the female (30 years).. Between the peri-urban and urban
respondents, there was a slight difference in the average
duration of education - 7 and 9 years respectively.
Description of findings
We identified ten different self-reported reasons why people
had refused to take part in various health studies. These
were:
Failure to follow traditional customs
Fear of strangers
Superstition
Poor informed consent procedure
Lack of study benefits
Ignorance of health research
Lack of cultural sensitivity
Poor timing
Previous bad research experience
Failure to follow traditional customs
The overall perception of the participants is that traditional
procedure has a big impact in making people decide whether
to take part in a study or not. They reported that failure to
conduct community engagement and failure to follow the
right protocol during recruitment of participants would make
people refuse to take part in research. The procedure they
suggested as a better practice was for interested researchers
to first seek consent from their chief or community leader
and then conduct sensitization meetings and a community
gathering where the whole community would be briefed
about the study. If the chief says yes to a research project
to take place in the area, his/her subjects would equally
feel secure to accept and take part in it. For example one
participant from Mpemba said
In response to the question ‘why is community engagement
important?’ several participants self-reported that community
engagement would give them a chance to understand more
information about the study and be able to ask questions
to the researchers before deciding whether to accept or
decline the research. They also reported that people refuse
to participate in studies when they are taken by surprise and
not informed in advance about the study. This leaves the
communities unprepared to decide whether to participate or
not. One participant said
Another participant said
Participants also argued that another advantage of
community engagement is that it would dispel rumours and
misconceptions that circulate in their communities.
Fear of strangers
Participants reported that people refuse to participate
in health studies when researchers are strangers in the
community. One participant reported
they should first inform the leaders of the community like
the chief and when they accept, the people would also accept
the research. But if they just come from wherever they come
from and start the research without involving our community
leaders, people will not accept it because they are not aware.
some researchers just arrive without informing the chief
and the people. We can refuse because we have not been
informed.”
the researchers were coming here all over a sudden.
They would just send a short message that we are coming
tomorrow and moreover among the visitors was a white
person. It is better maybe if they can start telling the
people this week that next week visitors will come.
it will be difficult for us to accept their research if they
just come without even wearing a uniform and being
people we have never seen them here before.”
MMJ 20(2) 2008 www.mmj.medcol.mw
59 why do people refuse to take part in biomedical research studies
Another respondent reported
However, several participants reported that they would be
comfortable to associate themselves with ordinary villagers
and local doctors they know.
Superstition and blood drawing
People refuse and express reservations if studies constitute
interventions that involve drawing of blood. This is tied to
beliefs where by blood is seen as a weapon used in witchcraft
for inflicting pain or sending pestilence to people. Belief in
and fear of witchcraft is the norm amongst most Malawians.
16 17
Other people also associate the drawing of blood with
rumours about blood sucking.18 They also fear that more
blood would be drawn from their bodies. Several participants
emphasized that studies that involve drawing of blood are
very risky and have a greater potential for refusal. One
participant observed
On the other hand, some participants said that they were
discouraged to take part in studies that involved taking of
blood simply because they were told that they would be given
presents if they consented to donate blood. For example,
one participant said
Other fears that were reported concerning drawing of blood
and dispensation of drugs include drawing more blood for
sale, and rumours that drugs being dispensed are intended to
make people barren or sterile. Participants said that people
see this as a government conspiracy to reduce population
growth. For example, one participant said that;
Poor informed consent procedures
Participants reported that people refuse to take part in studies
when researchers fail to explain clearly about the objectives
of their research. One participant said
Lack of study benefits
People decline to participate in research that does not provide
benefits which can either accrue to the individual or to the
area as a whole. Participants reported that they would like to
participate in studies that would benefit them and not just
to join studies only for altruistic reasons. For example, one
participant said
Ignorance of health research
Ignorance and lack of understanding about research are
some of the factors that would influence people’s refusal to
participate in health research. One participant observed
Another participant questioned
Analysis of the interviewees’ responses also shows that
many people especially from the rural areas are ignorant
about certain procedures in health research. One participant
who refused to take part in a malaria study expressed
discontentment over the use of medicated bed-nets. The
participant said
Similarly, several participants were not aware of the
rationale behind re-taking of blood samples every year
especially in longitudinal studies. One participant expressed
disappointment and said
Lack of cultural sensitivity
Several participants shared the view that they refused to
take part in studies where researchers were not respectful to
them. Participants observed from a number of studies that
people in the villages here are afraid to see strangers moving
from house to house, everybody would run away because we
have never seen such people in our community, for example,
there was this group of researchers that was going around the
villages with a white man distributing drugs and mosquito nets.
For us villagers, we rarely see white people in our homes. So it
was difficult to accept the drugs and mosquito nets which they
brought to us because we could not trust them.”
In magic, blood is revered and feared for the miraculous power
it possesses and confers. Blood is believed to unleash power.
most people fear that their blood will be drawn out if they
participate in research”.
People were discouraged to participate in the study because they
heard that participants who gave a bottle of blood in exchange
were given basins and wrappers.
at first I had refused to participate in the Onchocerciasis study
because there were a lot of things being said about it, that the
government wanted to make sure that many people are not
having many children since many of us are not going for family
planning [Participant is talking about distribution of
Mectizan drugs]. Many of us got scared with these stories.
But when we saw this other lady with skin itches all over her
stomach, we saw that what others were saying is not true. So we
changed our minds.”
“What people expect to hear is how the research would
be conducted and how the study will benefit them. If they
see that indeed things can improve, they can say yes, let the
study take place, mainly when they see that the study will be
beneficial in uplifting their health.”
“Sometimes it also depends on how the researchers explain
their research to people. If they do not explain it clearly,
people will not understand it and it will be difficult for them
to participate.”
“The other thing that researchers from the urban areas
should know when coming here is that they will be meeting
people from the village. And we lack understanding in most
things. It is important therefore to take time to explain to
us and come to an agreement. We should first be told the
purpose of the research before starting to conduct it so that
we should have time to think about it otherwise if we are
rushed we would refuse.”
“don’t researchers know that some of us never went further
with school? Instead of explaining properly so that we
understand, he sometimes spoke in English and that used to
confuse us as to what he really meant”.
“the white man tells me to sleep under a mosquito net that has
got medication in it. What if I wake up in the morning only
to find sores all over my body?”
“they can get blood today. A year can elapse before coming
again and request to take your blood again. You wonder as to
what they did with the blood they took the first time. People
refuse to participate because of that.”
Why do people refuse to take part in biomedical research studies 60
MMJ 20(2) 2008 www.mmj.medcol.mw
researchers were either disrespectful or did not know how to
approach the people. One participant said
Participants also noted that researchers overlooked the
importance of approaching husbands in studies that
targeted women. Researchers did not involve husbands of
the women they sampled during the consent seeking process.
This resulted in either many women refusing to participate
or husbands deterring their wives from taking part. One
participant said
Several participants were also dismayed and refused to join a
Mectizan drugs studies because researchers were measuring
people’s heights with a rigid ruler (wooden rod) to determine
dosage. Mostly a wooden rod is used to measure the height
of a dead body for funeral purposes. For example, one
participant said
Poor timing
Participants reported that there are certain periods of the year
when they are engaged in their fields with farming activities.
These moments are not convenient for rural participants to
enrol in research studies. They said that most people refuse
to take part during the rainy season when they work in their
farms. One participant from Madziabango said
Previous bad research experience
Participants reported that they would reject studies when
they look back at what similar previous studies had done to
them. If studies have not been helpful people would refuse
to join them. Similarly, they would decline to participate if
such studies harmed people’s lives. Many people reported to
have refused to take part in studies in which HIV testing was
involved due to psychological reasons. One participant said
Discussion
Several reasons why people refuse to participate in health
research have been revealed in this study. Many of these
might also be applicable to refusers in other similar settings.
Researcher
(Investigator)
Community Consultation
(Community Leader)
Community Sensitization
Community Ownership
Informed Consent
(Individuals)
(Married Couples)
Study Starts
Community Involvement
Community Permission
End of Study
Community Feedback
Figure 1: Community Engagement
Researcher
(Investigator)
Community Consultation
(Community Leader)
Community Sensitization
Community Involvement
Community Permission Community Ownership
Informed Consent
(Individuals)
Married couples
Study Starts
End of Study
Community Feedback
“researchers must talk to the people with love and patience.
They ought to know how to approach the people. They should
not threaten them. If people are threatened, they will not
listen to them. But if they talk to them with love, they would
definitely understand.”
“husbands of many women are very troublesome. Women
may be shouted by their husbands if they accept to take part
in a study right at the hospital. It would have been good if
researchers approached married couples in the villages and
explained to both of them together”
“on the issue of the rod, the dead are measured with a stick.
And they measure you with a stick too. This is not good.”
“during the farming period, people are busy. They have no
time for research. It is important to know the time people
are free to do things like research.”
“I refused to participate in the AIDS research because I
felt that if they found the virus in my blood I would be
a worried person and cannot live peacefully in my home
knowing that any day I will die.”
MMJ 20(2) 2008 www.mmj.medcol.mw
61 why do people refuse to take part in biomedical research studies
Participants in our sample were those who had previously
refused to take part in a number of different biomedical
research activities.
Participants in our sample reported that they would refuse
to participate in a study where the researchers failed to
follow the traditional custom. Figure 1 below illustrates
the traditional custom that participants want researchers to
follow. Following the traditional custom would benefit the
researcher because it would minimise unnecessary refusals.
What participants are referring to as traditional custom is in
fact community engagement, which we have modified to suit
the needs of all participants. This is illustrated in Figure 1.
Community engagement is a process of engaging community
members in research through consultation, sensitization,
involvement and providing feedback. In Figure 1, the steps
for community engagement show a lineal pattern with one
entry point for the researcher which is the community leader.
Participants agree that the researcher has to go through the
community leader. If the community leader accepts the study
then he or she should sensitize the community by organising
a meeting to involve them in the study. The community
involvement meeting should be attended by the researcher,
community leader and all the community members. Among
other things, during this meeting, the researcher is expected
to introduce and brief the community members about the
study. Community members should also have a chance to ask
the researcher questions where they do not understand. The
community can give its permission whether they want the
study to be conducted in their community. This also ensures
that the community members have ownership of the research
project. Informed consent process follows community
involvement. Single people can be invited to participate
individually while married persons can be interviewed as a
couple to facilitate joint decision making. Participants feel
that when all this is successfully carried out, then the study
can begin.
Participants stressed the importance of observing the
community engagement for successful recruitment and
informed consent. This demonstrates that people would
like to participate in studies if they are satisfied with the
rationale and information about the study. There is wide
acknowledgement of the need for community engagement
in biomedical research, particularly in developing countries.
Currently, engaging communities has become a critical aspect
of planning and implementing biomedical research. The
current international research ethics guidelines also talk of
community engagement as an ethical requirement for research
involving human subjects, particularly with marginalized
populations.19 Genuine community engagement offers
hope of enhancing recruitment, retention, and participant
satisfaction.
In addition to concerns with strangers, participants also
expressed discomfort with studies that involved drawing
of blood. These concerns can be addressed by adhering to
the village protocol in Figure 1. It would dispel any myths
about the study. Furthermore, the issue of fearing strangers
would not arise when researchers participate in community
engagement.
Our results raise an interesting point regarding the informed
consent procedure: poor informed consent with vague
explanation of objectives will discourage participation.
This brings up a long-running debate about how much
information about the study should be disclosed to
prospective study participants. There is no consensus on
this. If we argue that the information should be ‘as much
as possible’ then we beg another question; how much is ‘as
much as possible?’ According to the Belmont report, genuine
informed consent requires that participants should be given
sufficient comprehensive information and they should be
allowed to have enough time for consideration. They should
also be offered an opportunity to ask questions. This result
shows that the conduct of informed consent remains a big
challenge in settings with limited resources. More research
is needed about participants’ perceptions and experiences in
health research in settings with limited resources in order
to improve the informed consent processes. However, we
feel that adoption of the community engagement procedure
would demystify the conduct of informed consent in
resource poor settings.
Another important theme that emerged from this study
was the importance and application of the principle of
beneficence. Participants reported that they would not
participate in research studies which do not either benefit
them or the community. Participants also reported that some
studies set bad precedents which demoralise their future
participation in similar studies. Resource poor settings remain
potential targets for exploitative research.
Our results showed that people in peri-urban areas would
refuse to participate in health research owing to ignorance and
lack of understanding about certain concepts and procedures.
Researchers need to know the level of understanding
about health research of their potential participants. The
significance of using community engagement as a way of
informing the community about the study should therefore
not be underestimated. During community engagement, the
researcher can find out if there is need to educate potential
participants about certain procedures involved in the study.
Finally, another factor which contributes to people’s refusal
to take part is the concern that some researchers are not
conscious of local culture. Results show that participants
were disgruntled with researchers who were not friendly,
hospitable and lacked skills to properly approach participants.
Several participants from Mpemba and Madziabango said
that they were not happy to see researchers measuring heights
of people with a rod which is normally used to measure
corpses. Researchers should know more about the aspects
of culture of the people they would be investigating, and try
to anticipate the ways in which their actions and props like
measuring rods might be interpreted locally. A number of
researchers seem to be in a hurry to implement their studies
while neglecting the welfare of their participants. This
compromises the ethical conduct of research. Knowing the
culture, daily lifestyles, and opinions of participants would
help researchers know when and how to best approach their
participants.
Recommendations
The traditional customs suggested by the refusers constitute
the first step towards minimising refusals. We believe that
adequate community engagement will minimise refusals.
Why do people refuse to take part in biomedical research studies 62
MMJ 20(2) 2008 www.mmj.medcol.mw
We offer the following specific recommendations as principles
of community engagement which we have developed as a
result of this study.
Four Principles of Community Engagement in
Research
1. Community consultation
Brief the community leaders (chiefs, political leaders
and religious leaders) about the research project
- organize a meeting with them
- introduce the research project to the leaders
- explain in detail all the procedures involved in the
research
- outline any risks and benefits to individual participants
and to the community
- allow the leaders to ask questions about the
research project
- make sure you cover the topics listed in (3) below
- obtain their permission to conduct the research
project in their community.
Alternatively, you may approach the community
through meeting with a Community Advisory Board
(CAB) where one exists
- members of the CAB can then explain the project
to community leaders and seek their permission
for the research project to be conducted in their
community
When permission has been granted, the researchers,
community leaders and members of the CAB can organize a
community sensitization meeting.
2. Community sensitization
organize sensitization workshops for community
members
- inform them about the proposed research
- encourage a shared effort between researchers
and participants
- ensure that the research activities are responsive
to the needs of the community
- make sure that members of the community
understand what the research is all about
- define clearly the role that will be played by the
community members
- clarify any risks and any compensations
- allow community members to ask questions
about the project.
[Important: you should avoid providing information that
might lead to stigma and discrimination. For example,
if a research project is about HIV/AIDS and one of the
recruitment criteria is that potential participants have to be
HIV positive, this fact should not be made known to the
whole community, as they would then know that people
recruited in the study are HIV positive. A common solution
to this problem is to design the study so that both HIV+ve
and HIV-ve individuals are enrolled, and enrolment then
does not imply any individual’s HIV status.]
3. Community Ownership/partnership/involvement
Regard local communities participating in research as
partners or ‘owners’.
This partnership should begin before the conduct of
the research project and should continue during and
after the completion of the research project.
Agree in advance with the community leaders about
what will happen after the research is over
During any study, it is likely that the researchers will
need to respond to urgent needs of the community
or of individuals. As far as possible, agree in advance
with donors, Ethics Committee and community
leaders about the possible form and extent of such
assistance.
4. Feedback
When results are available, feed these back to research
participants and their community.
Make this effort, even if results may not be of
immediate benefit to participants, and despite the fact
that it may be difficult to trace all who took part in
the study.
Community feedback is another way of fostering
ownership (in this case, ownership of results).
We conducted feedback sessions about the results in our
study sites. We wrote a letter to the Clinical Officer-in-charge
of each of the health centres, informing them about our
schedule for the dissemination of results. We also requested
the local HSAs who had helped us with the recruitment
of participants to inform all the five categories of people
we had recruited. We prepared power point presentation
slides together with printed handouts in the local language,
Chichewa. About 80% of the participants were present
during the dissemination of results. Participants appreciated
this feedback. They reported that this was the first time they had seen
researchers disseminating results to the community in which they had
conducted their research.
Conclusion
We believe that most ‘refusers’ would have been willing
to participate in research if the above principles had been
carefully followed. Our findings require validation in a larger
sample from other settings in Malawi and other developing
countries, but meanwhile researchers need to take into
account the concerns raised by the refusers we interviewed.
Most of these concerns could be minimised by engaging the
community, both before research is initiated and after it has
been completed.
Acknowledgements
We would like to express our sincerely thanks and gratitude
to The Wellcome Trust for funding this study.
MMJ 20(2) 2008 www.mmj.medcol.mw
63 why do people refuse to take part in biomedical research studies
References
Benatar SR: Reflections and recommendations on research ethics in
developing countries. Social Science & Medicine 2002, 54:1131-1141
Zulfiqar AB: Ethics in international health research: a perspective from
the developing world. Bull World Health Organ 2002, 80:114-120
Shapiro HT, Meslin EM: Ethical issues in the design and conduct of
clinical trials in developing countries. N Engl J Med 2001, 345:139-
142
Khalil, S.S. et al. Attitudes, understanding, and concerns regarding
medical research amongst Egyptians: A qualitative pilot study. BMC
Medical Ethics 2007, 8 (9): 1472-6939
McCall, N., Trofimovich, L., and Bonito, A. Estimation and Analysis
of Non-Response Bias in Medicare Surveys. RTI International. August
2004
Lidz, W.S et al, “Therapeutic misconception and the appreciation of
risks in clinical trials. Social Science and Medicine”, 58(2004) 1689-
1697, pg 1689
The Belmont report. The National Commission for the Protection
of Human Subjects of Biomedical and Behavioral Research. April 18,
1979. http://ohsr.od.nih.gov
Jones J. The effects of non-response on statistical inference. J Health
Soc Policy 1996; 8: 49–62
Brody, J. L. & Waldron, H. B. Ethical issues in research on the treatment
of adolescent substance abuse disorders. Journal of Addictive
Behaviors 2000; Vol. 25, (2): 217-228. www.emhr.net
Smith, A., King, E., Hindley, N., Barnetson, L., Barton, J. & Kim, A.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
The experience of research participation and the value of diagnosis in
dementia: implications for practice. Journal of Mental Health 1998; 7:
309–321
Farre, M., Lamas, X. & Cami, J. Sensation seeking amongst healthy
volunteers participating in phase I clinical trials. British Journal of
Clinical Pharmacology 1995; 39: 405–409
Harrison, D. A. Volunteer motivation and attendance decisions:
competitive theory testing in multiple samples from a homeless shelter.
Journal of Applied Psychology1995; 80: 371–385
Ygge, B-M. & Arnetz J.E. A study of non-response in a questionnaire
survey of parents’ views of paediatric care. Journal of Nursing
Management, 2004, 12, 5–12
Pace, C., Grady, C., & Emanuel E.J. What we don’t know about
informed consent? 2003. www.scidev.net
Bernard H: Social Research Methods: Qualitative and Quantitative
Approaches. London, UK: Sage Publications; 2000
Guiley, R. E. 1999. The Encyclopedia of Witches and Witchcraft,
second edition, p. 26. New York: Facts on File
Mather, G.A. & Nichols, L.A. 1993. Dictionary of Cults, Sects, Religions
and the Occult, p.40. Michigan: Zondervan Publishing House
Kavinya T 2007, A deeper look, interview with Bridon Mbaya. Malawi
Medical Journal Vol 19, issue 2 www.mmj.medcol.mw/adeeperlook20
07vol19.2.htm
Sapienza, J. N., et al., Community engagement in Epidemiological
Research. 2007 May-Jun; 7(3):247-52. Ambulatory Pediatric
Association. p. 252
11.
12.
13.
14.
15.
16.
17.
18.
19.
The Centre for Bioethics in Eastern and Southern Africa
(CEBESA) in collaboration with College of Medicine
Research and Ethics Committee (COMREC), National
Health Science Research Council (NHSRC), and Pharmacy
Medicines and Poisons Board (PMPB) hosted a two day
workshop on Enhancing Clinical Trial Oversight in Malawi”
on the 19th and 20th June at Nkopola Lodge in Mangochi.
The workshop was funded by the European and Developing
Counties Clinical Trials Partnership (EDCTP) through a
grant on strengthening national capacities in ethical review
and clinical trial monitoring. The aim of the workshop was
a critical look at research oversight in Malawi particularly in
light of the implementation of sections of the PMPB Board
Act of 1988 related to clinical trials. The workshop brought
together stakeholders in health research from various
institutions including University of North Carolina, Malawi
Liverpool Wellcome Trust, University of Mzuzu, Kamuzu
College of Nursing, Centre for Reproductive Health, College
of Medicine and Blantyre Malaria Project. Also present at
the workshop was Medical Rights Watch a medical student
led organization whose goal is to promote and protect the
rights and responsibilities of patients, research participants
and health practitioners in Malawi.
Professor Joseph Mfutso-Bengo, Director of CEBESA and
organizer of the workshop welcomed all the participants.
The workshop was opened by the Principal of the College
of Medicine, Professor Broadhead and was followed by
an oversight of COMREC by the Postgraduate Dean
Professor Eric Borgstein. Paul Ndebele of CEBESA gave an
introductory presentation on regulatory oversight of clinical
trials. Mr. Aaron Sosola, Deputy Registrar of PMPB, gave
a perspective of the PMPB, the PMPB Board Act and the
systems and procedures that have been put into place by
the Board regarding clinical trial monitoring. The workshop
gave an opportunity for the PMPB to update stakeholders
on the introduction of the clinical trial monitoring program
which requires all research institutions to register their
clinical trials with the Board. It was made clear that ethics
and review committees (COMREC, NHSRC) and drug
regulatory agencies (PMPB) have separate and distinct
areas of focus. However there was consensus that further
discussions need to be held amongst the stakeholders to see
how best to harmonize the PMPB clinical trial monitoring
with other existing systems. Participants discussed important
issues related to the conduct of clinical trials this included
whether submission of clinical trials should be concurrent or
consequential to PMPB and ERCs, how the PMPB’s Clinical
Trial Review Committee can function efficiently, how ERCs
and PMPB can cooperate, how to update researchers on
the new measures and prepare research sites for the new
developments. Participants were given the opportunity
to review and comment on PMPB documents and make
recommendations on the documents.
At the end of the workshop participants were familiar with
PMPB legislation for clinical trials, and the PMPB tools and
procedures to be used for regulating research. This workshop
sensitized stakeholders on the impending new measures
and gave the opportunity to stimulate what is hoped to be
Report on the workshop “Enhancing Clinical Trial
Oversight in Malawi”
... Apart from furthering the knowledge about a particular field of study (Vong, 2017), publishing articles in peer-reviewed journals has also become an essential part of a successful career progression, promotional decisions, compensation, and career mobility, and may also impact the reputation of higher education institutions (Chan et al., 2005). Although researchers continue to guide policy development and direction in countries such as Australia, the US, and the UK, little research is shared or published to guide and direct policy formulation in non-Western contexts (Mfutso-Bengo et al., 2008;Sadana et al., 2004;Ito et al., 2014). According to Sadana et al. (2004), this denies international development partners or policymakers the chance to make decisions based on evidence made available through research. ...
... There has also been an attempt to understand the perception of academics or researchers towards the peer review process, publishing, and conducting research (Abdullah & Noorhidawati, 2020; Gaus & Hall, 2016;Jordan, 2022;Machimbidza & Stephen Mutula, 2018;Mfutso-Bengo et al., 2008;Phothongsunan, 2016;Rowley & Sbaffi, 2017;Suhaimi et al., 2020). For instance, Rowley and Sbaffi (2017) examined attitudes towards peer review among 86,487 authors who published with Taylor & Francis or Routledge in 2013. ...
... This is in the context of other barriers concerning participation in biomedical and population health research (Crampin et al., 2012;Matandika et al., 2020;Mbililishaka, 2018;Mezinska et al., 2020). Notable among these are the issues mentioned above of participant trust, alongside researcher trustworthiness (Creswell, 2013;Mfutso-Bengo et al., 2008;Mfutso-Bengo et al., 2015). ...
... This implies evidence of trust and solidarity between communities within MEIRU sites, HCPs, and researchers. It also demonstrates that trust in researchers and open communication could profoundly influence decision-making and acceptability, especially when introducing new and potentially sensitive research procedures (Creswell, 2013;Mfutso-Bengo et al., 2008;Mfutso-Bengo et al., 2015). This increases yet further researchers' responsibilities to enact and demonstrate trustworthiness. ...
... To our best of knowledge, only one study has documented the factors explaining one's decision for participating or refusal to take part in a study. A rare example is a health research conducted in Malawi by Mfutso-Bengo et al. [16]. The study used focus group discussion to document the experiences of participants who had refused to take part in an empirical research. ...
... The findings suggest that there are some key stakeholders in education who do not see the benefit of inclusive education research. The study finding is inconsistent with a previous study in Malawi which found cultural barriers as reasons for refusal of participants to contribute to medical research [16]. ...
Article
Full-text available
Objective The importance of research cannot be overemphasized. Research findings serve as a guide for the enactment of development policies and legislation. However, not all members of the target population willingly participate in a study. The current study explored the reasons why some individuals refused to partake in inclusive education research in a developing country, Ghana. The journaling helped to capture the voices of 87 participants who refused to take part in a larger inclusive education survey study. Results The study found that the participants did not take part in the research because of reasons such as lack of financial gain, bad experience with previous research, lack of direct benefit, and lack of time. The findings of the study and its implication for policymaking in Ghana and research studies in sub-Saharan Africa are discussed.
... Researchers usually have to manage limited resources for their research, and having knowledge about facilitators and barriers of research, especially during the recruitment stage, can be helpful for better planning and overcoming challenges. In the past two decades, numerous studies have examined recruitment in various contexts [3,[5][6][7], and have reported on barriers, motivations, and recruitment strategies that vary based on the research setting, methodology, and target population [8]. ...
... Research to identify etiological agents, disease management, and cost-benefit analysis is essential for defining what interventions should be implemented and what the likely impact would be in the contexts where they will be applied [13]. However, biomedical research involving human subjects, especially in the context of scarce resources, faces many barriers [5]. ...
Article
Full-text available
Background Understanding the barriers to and facilitators of participation in research could enhance recruitment rates for biomedical research on Neglected Tropical Diseases (NTDs) and help to avoid the problems associated with poor recruitment. Methodology/principal findings We conducted a systematic review to identify factors related to willingness to participate in biomedical research on Neglected Tropical Diseases (NTDs). Our search included the following databases: Medline/PubMed, Embase (Embase.com), Global Index Medicus (WHO), Web of Science (Core collection), and gray literature. We included studies that analyzed or reported factors associated with willingness to participate in NTD research, using either quantitative methods (such as clinical trials, cohorts, and cross-sectional studies) or qualitative methods (such as focus group discussions, semi-structured interviews, and in-depth interviews). There were no language restrictions, but we excluded review articles, notes, case reports, letters to the editor, editor’s notes, extended abstracts, proceedings, patents, editorials, and other editorial materials. Screening of citations, data extraction, and risk of bias assessment was conducted by independent reviewers, according to the study protocol registered on PROSPERO. For analyses, we assessed the frequency of barriers, enablers, and the frequency of recruitment interventions mentioned in the included studies. The protocol for this systematic review was registered under registration number CRD42020212536. (S1 Appendix) We identified 2070 citations, 1470 from the databases, and 600 from other sources. From those, eleven studies were selected for data extraction and analysis. The studies were conducted in Africa, Asia, and North America. Personal health benefits, monetary benefits, and community engagement and sensitization strategies were identified as the main reasons for participating in biomedical research on Neglected Tropical Diseases (NTDs). However, distrust in researchers, lack of knowledge about research methods among potential participants, and previous negative experiences were identified as the main barriers to participating in biomedical research on NTDs. Conclusions/significance This systematic review provides recommendations for improving adherence to biomedical research on Neglected Tropical Diseases, which can be applied in practice.
... In the age of conspiracy theories, the African continent which has faced several violations. A study by (Mfutso-Bengo et al., 2008) discovered in Malawi that participants were prepared to partake in research purposes if they were given enough information and reassurance regarding the use of their data post-research. Another study in Qatar by (Tohid et al., 2017) found that participants either agreed or declined to partake in research studies influenced by fear of the outcome of the study and lack of interest (Del Brutto et al., 2018). ...
... found no dominant influence of culture and religion in the decision-making to partake in specific shared treatment schemes and declared their attitudes not culturally sensitive. In controversy, a study in Malawi by (Mfutso-Bengo et al., 2008). Found that the interviewees declined earlier biomedical research participation because of the failure of the research to uptake cultural values and lack of cultural sensitivity, among others. ...
Preprint
Full-text available
It contains the researchers capstone research project in defense for a Bachelor’s honors in Global Challenges with a mission in healthcare at the African Leadership University. The paper details all the steps and information used by the student from project conception to research and report.
... developing a common language between communities and researchers are tasks researchers and CSOs must conduct. Furthermore, creating a dialogue network to share perceptions among residents, traditional communities, academic actors, and public managers is the responsibility of researchers, local actors, CSOs, and public managers (Mfutso-Bengo et al., 2008). Returning project and research results to communities is a mutually beneficial practice for both communities and researchers (Hintz and Dean, 2020). ...
Article
Full-text available
The complementary use and transfer of empirical and scientific knowledge are essential for the holistic and sustainable management of fishing resources. To understand how both types of knowledge are transferred in fishing communities in three regions of Mexico, we conducted 120 in-depth interviews with young people, adults, and older adults who participated in various activities within fishing value networks. During the interviews, we identified who participated in transferring knowledge within communities, what lessons were passed on, what knowledge has been lost, and what scientific topics are known within the communities. We also investigated the sector’s most used means of communication to further explore the transfer of scientific and technical knowledge and the fundamental roles of external actors in transferring knowledge within communities. The information was coded, categorized, and analyzed for each question. The interviewees valued the continuity of inheriting traditional knowledge, which included teaching practical skills, such as fishing techniques and navigation, and transmitting values, traditions, and ways of understanding and relating to the marine environment. The interviewees perceived knowledge transfer as a bidirectional exchange of knowledge, ideas, and practices among generations. Furthermore, they recognized the value of external actors with scientific and technical knowledge in promoting innovation and adapting to new challenges. The combination of knowledge and perspectives enriches fisheries management and marine environmental conservation. Promoting the transfer of traditional and scientific knowledge is fundamental to building a future where fishing and marine life coexist in harmony and prosperity. The responsibility of supporting this integration falls on fishing communities and external actors. Working together in this collaborative learning process is the key to achieving sustainable resource management and ensuring the continuity of this valuable tradition for future generations. In doing so, these communities’ cultural and ecological richness can be preserved, ensuring a lasting balance between people and the sea.
... Communities may be reluctant to grant researchers access for various reasons including lack of trust and these challenges can be overcome by employing effective community engagement strategies. 11 When conducting research, it is important to establish a strong connection within the community and ensure effective channels of communication. 12 13 Communicating effectively with key stakeholders and community members helped facilitate our community entry process as well as improved the participation of the community members. ...
Article
Full-text available
Effective community entry processes influence community participation and acceptance of public health interventions. Though there is a growing body of literature on the importance of community partnerships, there is a lack of pragmatic and practical documentation of the experiences involved in the community entry process as it relates to culturally sensitive topics such as child marriage which can help to support researchers working in this field. This article highlights key themes related to knowledge of the community, effective communication, cultural sensitivity, coproduction and giving feedback which help to build trust between the community members and the research team. Institutional representation, not managing expectations, and lack of clarity, along with personal opinions of community gatekeepers can create challenges for the fostering of trustworthy relationships with the community. These realities must be actively addressed right at the onset of the process between the research team and community stakeholders. Researchers can develop trust, form connections and engage different communities by working with local groups and leaders, using culturally appropriate methods, and addressing community concerns. Future projects working with communities on child marriage in Nigeria and other countries would benefit from the reflections presented in this paper.
... This framework has been criticized as conceptually confusing [15], and it may not be consistent with how researchers and participants think about such payments. This limitation may be exacerbated in international settings where different experiences and perceptions may influence payment practices and how payments are described or translated [43,44] and may explain the differences reflected in Table 3. Nevertheless, these data provide an important starting point for further research on research payment and ways to make such payments more equitable. ...
Article
Full-text available
Empirical data regarding payments to participants in research is limited. This lack of information constrains our understanding of the effectiveness of payments to achieve scientific goals with respect to recruitment, retention, and inclusion. We conducted a content analysis of consent forms and protocols available on clinicaltrials.gov to determine what information researchers provide regarding payment. We extracted data from HIV (n = 101) and NIMH-funded studies (n = 65) listed on clinicaltrials.gov that had publicly posted a consent form. Using a manifest content analysis approach, we then coded the language regarding payment from the consent document and, where available, protocol for purpose and method of the payment. Although not part of our original planned analysis, the tax-related information that emerged from our content analysis of the consent form language provided additional insights into researcher payment practices. Accordingly, we also recorded whether the payment section mentioned social security numbers (or other tax identification number) in connection with payments and whether it made any statements regarding the Internal Revenue Service or the tax status of payments. We found studies commonly offered payment, but did not distinguish between the purposes for which payment may be offered (i.e., compensation, reimbursement, incentive, or appreciation). We also found studies that excluded some participants from receiving payment or treated them differently from other participants in the study. Differential treatment was typically linked to US tax laws and other legal requirements. A number of US studies also discussed the need to collect Social Security numbers and income reporting based on US tax laws. Collectively, these practices disadvantage some participants and may interfere with efforts to conduct more inclusive research.
... Assuming an expected frequency of 10.00%, consistent with previous studies, and for a 95% confidence interval (95% CI), this implied a minimum sample size of 138 women [18]. Based on analogous studies in the same region, we also assumed a design effect of 2.00 [19] and considered a refusal to participate rate of 10.00% [20]. Thus, we defined a minimum recruitment target of 304 women to achieve a minimum sample size of 276 participants. ...
Article
Full-text available
Background Sickle Cell Disorder is Africa’s most prevalent genetic disease. Yet, it remains a neglected condition, with high mortality under-five, and a lack of population-based studies in the region. This is the first of its kind in São Tomé e Príncipe, aiming to estimate the prevalence of sickle cell trait and other haemoglobin variants in women of reproductive age and its associated factors. Methods We conducted a cluster survey in 35 neighbourhoods. Haemoglobin was assessed through point-of-care capillary electrophoresis or high-performance liquid chromatography, and sociodemographic data through questionnaires. The weighted prevalence of sickle cell trait (HbAS) and HbC carriers was estimated with a 95% confidence interval (95% CI). We calculated weighted prevalence ratios (95% CI) through robust Poisson regression for its association with age and individual and collective genetic heritage. Findings The prevalence of sickle cell trait in women of reproductive age in São Tomé e Príncipe (n = 376) was 13.45% (95% CI: 9.05-19.00). The prevalence of HbC carriers was 8.00% (95% CI: 4.71-12.00). Older age and speaking Forro or Angolar were positively associated with having sickle cell trait. Interpretation The prevalence of sickle cell trait in São Tomé e Príncipe ranks high in the West African region. The country should follow international guidelines, implementing newborn screening and comprehensive healthcare management.
Article
Full-text available
This paper aims to evaluate the implementation of Competency-Based Education (CBE) models in Ghana's nursing and midwifery training colleges, focusing on bridging the gap between theory and practice. A comprehensive literature review and analysis of recent studies were conducted, examining cultural and contextual factors, healthcare system context, challenges in nursing education, and capacity building efforts. The findings reveal significant challenges in clinical placements, quality assurance, and alignment of competencies with cultural and healthcare system needs. While CBE implementation shows promise, it is hindered by resource constraints, limited faculty capacity, and inadequate integration of cultural factors. The paper concludes that current approaches are not fully adequate to address the complex interplay of factors affecting nursing education in Ghana. Recommendations include developing culturally specific competencies, strengthening partnerships between educational institutions and healthcare facilities, and implementing a comprehensive capacity building strategy. These findings are significant for enhancing the quality and relevance of nursing and midwifery education in Ghana, potentially leading to improved healthcare outcomes.
Article
Full-text available
The process underlying participation in episodic volunteer work is conceptualized as a form of attendance motivation. A decision-making theory of attendance motivation is expanded for the voluntarism context, then competitively tested against nested theories: the theory of planned behavior (I. Ajzen, 1991), the theory of reasoned action (M. Fishbein, 1980), and a benchmark theory emphasizing the subjective expected utility of anticipated rewards. Tests are conducted in a field study (n = 53) predicting the motivation and attendance of male volunteers scheduled to work roughly 1 night per month at a homeless shelter. One panel (n = 53) and 2 cross-sectional (n = 51; n = 53) replications of the field study are also described. Results are consistent across time and samples in their support of the expanded theory primarily because it includes a moral obligation component.
Article
Full-text available
Surveys have been, and will most likely continue to be, the source of data for many empirical articles. Likewise, the difficulty of making valid statistical inferences in the face of missing data will continue to plague researchers. In an ideal situation, all potential survey participants would respond; in reality, the goal of an 80 to 90% response rate is very difficult to achieve. When nonresponse is systematic, the combination of low response rate and systematic differences can severely bias inferences that are made by the researcher to the population. It is important for the researcher to assess the potential causes of nonresponse and the differences between the observed values in the sample compared to what may have been gained if the sample was complete, particularly when the response rate is low. There are methods available that substitute imputed values for missing data, but these methods are useless if the researcher lacks knowledge of how the responders and nonresponders may differ. With regard to statistical inference, the researcher also should be aware of the difference between a convenient sample and a probability sample. Valid statistical inference assumes that the probability of characteristics observed in the sample bear some relationship to their occurrence in the population. For example, in a simple random sample each member of the accessible population has an equal chance of inclusion in the sample. A convenient sample lacks the statistical properties of a probability sample that allow the validity of its inferences to be assessed strictly from a mathematical framework. The context of the research and the type of data being gathered greatly affect the validity of any generalizations the researcher makes with regard to the population the convenient sample attempts to represent.
Article
The aim of this study was to examine whether there were differences in quality ratings between respondents and non-respondents to a questionnaire concerning parents’ views of paediatric care. This study also examined whether quality ratings differed when questionnaire respondents were asked to reassess certain aspects of hospital care in a follow-up questionnaire. A total of 1094 questionnaires were distributed to parents at the hospital. Three weeks later, follow-up questionnaires were sent home to a random sample of 140 parents who had visited the hospital during the 2 weeks when the main questionnaire was distributed. Forty-six per cent of respondents to the follow-up questionnaire had never received the original questionnaire in hospital, while only seven individuals in the follow-up sample were active non-respondents. Analysis of variance revealed that respondents to the follow-up questionnaire who had never received the main questionnaire did not differ significantly from respondents to the main questionnaire in their ratings of key quality domains. There were no statistically significant differences in quality ratings between parents who responded to both questionnaires and parents who responded to the main questionnaire. For hospital management, it is important to be able to trust questionnaire results. Non-response bias can jeopardize the validity of questionnaire results, which is why studies of non-response are important. The current study pinpoints a number of difficulties that need to be considered when conducting investigations of non-response.
Article
1. Phase I clinical trials are usually carried out in healthy volunteers. In addition to economic gain, factors that may influence willingness to participate include scientific interest, curiosity and choice for risky activities. 2. We assessed the relationship between personality variables and volunteering for clinical pharmacology research. Two personality questionnaires, the Sensation Seeking Scale (SSS, form V) and the Eysenck Personality Questionnaire (EPQ), were administered to 48 male healthy university students who volunteered to participate in a phase I clinical trial and to 43 male university students who were not willing to participate in phase I clinical trials. General norm data were also used for the comparison of results. 3. When healthy volunteers were compared with unwilling subjects, significant differences were found in thrill-and-adventure seeking (7.9 vs 6.7, P = 0.0034), experience seeking (6.4 vs 5.2, P = 0.0012), disinhibition (6.2 vs 4.3, P < 0.0001), boredom susceptibility (3.9 vs 2.8, P = 0.0073), total sensation seeking trait (24.3 vs 19.0, P < 0.0001), extraversion (15.1 vs 13.3, P = 0.0490), and psychoticism (4.4 vs 3.5, P = 0.0086). When healthy volunteers were compared with general norm data similar statistically significant differences were found in all these scales, except for boredom susceptibility and psychoticism. 4. The personality profile of healthy volunteers was characterized by a higher sensation seeking trait and extraversion as compared with individuals who were not willing to participate in phase I clinical trials and general norm data.
Article
Treatment research on adolescent substance use disorders raises a number of important ethical and legal concerns which have not been widely acknowledged. This paper explores these concerns as they relate to fundamental ethical principles in the conduct of human research. The issues discussed include tensions between conflicting regulations governing informed consent for research and treatment of adolescents, the capacity of adolescents to give informed consent, potentially coercive elements related to research on substance use treatment, problems associated with confidentiality and release of information, research vulnerability associated with substance use, and ethical implications of distinctions between effectiveness and efficacy research. Suggestions for ways investigators may address these concerns are provided.
Article
This article has no abstract; the first 100 words appear below. There has been considerable controversy about the ethics of clinical trials that are sponsored or conducted by groups in industrialized countries but carried out in developing countries.¹–⁸ The National Bioethics Advisory Commission, of which we serve as chairman and executive director, respectively, has recently addressed these and related issues.⁹ International collaborative research covers a broad spectrum of methods, topics, and research strategies. In this essay, we discuss ethical issues in the design and conduct of clinical trials in developing countries. In particular, we focus on phase 3 and other drug trials that, if successful, can lead to the use . . . Harold T. Shapiro, Ph.D. Eric M. Meslin, Ph.D. National Bioethics Advisory Commission, Bethesda, MD 20892-7979 We are grateful to members of the National Bioethics Advisory Commission and others for discussions and contributions.
Article
Health research plays a pivotal role in addressing inequities in health and human development, but to achieve these objectives the research must be based on sound scientific and ethical principles. Although it is accepted that ethics play a central role in health research in developing countries, much of the recent debate has focused on controversies surrounding internationally sponsored research and has taken place largely without adequate participation of the developing countries. The relationship between ethical guidelines and regulations, and indigenously sponsored and public health research has not been adequately explored. For example, while the fundamental principles of ethical health research, such as community participation, informed consent, and shared benefits and burdens, remain sacrosanct other issues, such as standards of care and prior agreements, merit greater public debate within developing countries. In particular, the relationship of existing ethical guidelines to epidemiological and public health research merits further exploration. In order to support health research in developing countries that is both relevant and meaningful, the focus must be on developing health research that promotes equity and on developing local capacity in bioethics. Only through such proactive measures can we address the emerging ethical dilemmas and challenges that globalization and the genomics revolution will bring in their wake.
Article
The debate on the ethics of international clinical research involving collaboration with developing countries has achieved a high profile in recent years. Informed consent and universal standards have been most intensively debated. Exploitation and lack of adequate attention to justice in the distribution of risks/harm and benefits to individuals and communities have to a lesser extent been addressed. The global context in which these debates are taking place, and some of the less obvious implications for research ethics and for health are discussed here to broaden understanding of the complexity of the debate. A wider role is proposed for research ethics committees, one that includes an educational component and some responsibility for audit. It is proposed that new ways of thinking are needed about the role of research ethics in promoting moral progress in the research endeavour and improving global health.
Article
Studies repeatedly have shown that clinical research subjects have trouble appreciating the implications for their clinical care of participating in a clinical trial. When this failure is based on a lack of appreciation of the impact on individualized clinical care of elements of the research design, it has been called the "therapeutic misconception". Failure to distinguish the consequences of research participation from receiving ordinary treatment may seriously undermine the informed consent of research subjects. This article reports results concerning appreciation of the risks of trial participation from intensive interviews with 155 subjects from 40 different clinical trials at two different medical centers in the USA. Working from transcripts of the interviews, every statement of a risk or disadvantage of trial participation was identified and coded into one of 5 different categories. Totally, 23.9% of subjects reported no risks or disadvantages in spite of being explicitly asked about them. Another 2.6% reported only incidental disadvantages such as having to drive a long way to get to the experimental site. In all 14.2% reported only disadvantages associated with the standard treatment (usually side effects). Another 45.8% told the interviewer about disadvantages and risks associated with the experimental intervention (usually side effects). Only 13.5% could report any risks or disadvantages resulting from the research design itself, such as randomization, placebos, double-blind designs and restrictive protocols. The results of this research suggest that subjects often sign consents to participate in clinical trials with only the most modest appreciation of the risks and disadvantages of participation.